DAXOR
About:
DAXOR Corporation is an innovative medical instrumentation and biotechnology company.
Website: http://daxor.com
Twitter/X: daxorbva
Top Investors: National Institutes of Health, Launch Tennessee
Description:
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
$13.9M
$1M to $10M
New York, New York, United States
1970-01-01
info(AT)daxor.com
Joseph Feldschuh
1-10
2024-09-05
Public
© 2025 bioDAO.ai